Skip to main content
Premium Trial:

Request an Annual Quote

Bruker's Revenues Jump 27 Percent in Q4 as Service and Product Sales Up

NEW YORK (GenomeWeb News) — Bruker BioSciences today said fourth-quarter revenues increased 27 percent as R&D spending rose 23 percent and profit nearly doubled.
Total receipts for the three months ended Dec. 31, 2006, increased to $135.6 million from $106.7 million year over year.
Product revenue increased 25 percent to $120.4 million; service revenue increased 45 percent to $15 million; and “other” revenue decreased 48 percent to $146,000.
CEO Frank Laukien said the acquisition of Bruker Optics and other expansions added to revenue for the year. He said the company “continued to strengthen both our traditional research systems business and our newer industrial and applied analysis business,” and added that the fourth quarter was “particularly strong.”
Bruker said profit surged 98 percent to $9.7 million from $4.9 million in the year-ago period.
Bruker said it had around $52.7 million in cash and equivalents and short-term investments as of Dec. 31.
Laukien said the company expects revenue to grow more than 10 percent in 2007.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.